Nutrition and Obesity Resource Center

Nutrition and Obesity Treatment

AACE is at the forefront of treatment of patients with obesity, a chronic disease that affects approximately one-third of Americans. Our resources will help you identify effective weight-loss strategies for your patients, including:

Supportive lifestyle intervention
Pharmacologic management
Bariatric surgery
Nutrition and appetite control

If you're interested in nutrition and obesity, you may enjoy episode 2 of the new AACE Podcasts.

CLINICAL QUIZ: Nutrition and Obesity Case Questions

Obesity Case 12

A 47-year-old woman with primary hypothyroidism and osteoarthritis of the right knee presented to the clinic for follow-up. She is trying to lose weight in preparation for right knee surgery. The weight loss has plateaued on a low-calorie meal plan. Her exercise is limited by chronic knee pain. She tracks her calories and daily steps. After the discussion about the risks and benefits of weight loss medications, she was started on phentermine/topiramate extended-release daily. She returns three months later and has lost 3% of her body weight since the last visit. On physical examinati

Obesity Case 11

A 63-year-old African American male with a history of obesity, T2DM, CKD3b and recent NSTEMI was referred for cardiometabolic risk optimization.

Medications: atorvastatin 80mg, lisinopril 20mg, aspirin 162mg, metformin 1000mg bid, metoprolol 50mg daily, duloxetine 20mg daily

Diet:

Obesity Case 9

A 27 year-old woman with a history of obesity, polycystic ovary syndrome (PCOS) and primary hypothyroidism is referred to you for recent weight gain. She also has a history of recurrent kidney stones. Despite her best efforts to follow a meal plan as prescribed by a registered dietitian and increasing her physical activity by hiring a personal trainer, she has gained 20 pounds in the 6 months prior to her visit with you. She reports recent trouble with portion control.

View all Nutrition and Obesity Treatment

CLINICAL PRACTICE GUIDELINES

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults

Cosponsored by American Association of Clinical Endocrinology and The Obesity Society

These AACE/ACE evidence-based clinical practice guidelines address key aspects of obesity care: screening, diagnosis, clinical evaluation, treatment options, therapy selection, and treatment goals.

View all Guidelines

TREATMENT ALGORITHM

Treatment Algorithm for the Medical Care of Patients With Obesity

Use AACE's step-by-step interactive guide to successfully implement a multifaceted patient care plan with evidence-based obesity treatment strategies.

View all Treatment Algorithms

SLIDE LIBRARY

Integrating Obesity Medicine into Your Practice

Do you want to incorporate obesity medicine into your medical practice but don't know where to start? The disease of obesity is increasing at an alarming rate in the US and worldwide.

View Slides

Individualizing Weight Loss Therapy

Help your patients understand Obesity is a disease and it needs to be treated. Obesity is quickly becoming an epidemic in the United States.

DOWNLOAD FILE (PDF)

Clinical Benefits of Weight Loss

Key Points

Obesity is a chronic relapsing progressive disease defined by abnormal or excessive adiposity that may impair health.
Improved ability to engage in activities of daily living such as improved mo

Download Slides (PDF)

View all Slide Library

RESOURCE TOOLKITS

AACE Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Off-label use and misuse of testosterone, GH, thyroid hormone, and adrenal supplements have become increasingly prevalent. Many patients seek treatment for common nonspecific symptoms such as fatigue, low energy, poor sleep, weight gain, and lower libido. Unfortunately, some clinics and websites lead people to believe that their symptoms are attributable to a deficiency of a hormone and that treatment with this hormone will eliminate their symptoms.

Office Tools

Drug Information Tools for Patients

View all Resource Toolkits

IN-DEPTH INFORMATION

View all In-depth

Section 1. What Is the Disease of Obesity?

AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity Recommendations

Section 2. Why Do We Treat Obesity?

Obesity prevalence has risen steadily for several decades, and the disease, its complications, and comorbidities place a huge burden on patients and society. Obesity is estimated to add $3,559 annually (adjusted to 2012 dollars) to per-patient medical expenditures as compared to patients who do not have obesity; this includes $1,372 each year for inpatient services, $1,057 for outpatient services, and $1,130 for prescription drugs.

Section 3. How Do We Treat Obesity?

The primary therapeutic goal of obesity management is improvement in adiposity-related complications, not a preset decline in body weight. Lifestyle intervention is a vital component of all weight loss regimens; the choice of whether to implement lifestyle therapy alone or combine it with weight-loss medications or bariatric surgery will depend on the severity of each individual patient’s obesity and related complications.¹

SCIENTIFIC ARTICLES

Endocrine Practice - the Journal for Clinical Endocrinology

Endocrine Practice, our official journal, keeps you on the leading edge of endocrine patient care.

AACE Clinical Case Reports

Access a wide range of case reports, visual vignettes and commentary from noted endocrinology experts.

Association Between the Serum Uric Acid Level and the Body Mass Index in Sex- and Age-Specific Groups in Southwestern China

This study was to investigate the sex- and age-specific association between the serum uric acid level and the body mass index.

View all Articles

Renew Your AACE Community Membership for 2023 Learn More